Dapagliflozin 10mg + Sitagliptin 100mg Tablets

Dapagliflozin 10mg + Sitagliptin 100mg combines two glucose-lowering medicines for adults with type 2 diabetes. It brings together complementary approaches when a single medicine does not provide adequate blood glucose control alongside diet and activity.
Swallow the tablet with water at a consistent daily time, with or without food. Maintain normal fluid intake. A planned fast, operation or illness causing poor food and fluid intake may require a temporary treatment change.
Dapagliflozin blocks kidney SGLT2 transporters to increase glucose excretion in urine. Sitagliptin inhibits DPP-4, prolonging incretin activity to support glucose-dependent insulin release and reduce glucagon.
Genital fungal infection, increased urination, thirst and dizziness can occur. Severe abdominal pain, repeated vomiting or difficult breathing can indicate ketoacidosis even when glucose is not very high.
Kidney function, dehydration and recurrent genital infection affect suitability. It is not a treatment for type 1 diabetes or diabetic ketoacidosis. Insulin or sulfonylureas can increase hypoglycaemia risk when combined with it.
The complementary actions can lower glucose through the day without relying on a single insulin-related pathway.
Passing glucose into urine is an intended effect of dapagliflozin. Urine glucose alone therefore cannot show whether diabetes is adequately controlled.
Itching, redness, soreness or unusual genital discharge can occur. Early treatment helps prevent the infection becoming more troublesome.
Yes. Nausea, abdominal pain, vomiting, unusual tiredness or deep rapid breathing needs urgent assessment and ketone testing rather than reassurance from glucose alone.
Its mechanisms have a relatively low hypoglycaemia risk, but the risk rises with insulin or a sulfonylurea. Repeated low readings can require adjustment of those medicines.
HbA1c shows average glucose over roughly 2 to 3 months. Home glucose readings add information about daily patterns and episodes of low glucose.
SGLT2: a kidney transporter that reabsorbs glucose. DPP-4: an enzyme that breaks down incretin hormones. HbA1c: a measure of average blood glucose. Ketoacidosis: a dangerous build-up of ketones and acid in the blood.; AR: Dapagliflozin 10mg + Sitagliptin 100mg أقراص; FR: Dapagliflozin 10mg + Sitagliptin 100mg comprimés; PT: Dapagliflozin 10mg + Sitagliptin 100mg comprimidos; ES: Dapagliflozin 10mg + Sitagliptin 100mg comprimidos; RU: Dapagliflozin 10mg + Sitagliptin 100mg таблетки; ID: Dapagliflozin 10mg + Sitagliptin 100mg tablet; VI: Dapagliflozin 10mg + Sitagliptin 100mg viên nén; MS: Dapagliflozin 10mg + Sitagliptin 100mg tablet; TL: Dapagliflozin 10mg + Sitagliptin 100mg mga tableta; ZH-SG: Dapagliflozin 10mg + Sitagliptin 100mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Dapagliflozin 10mg + Sitagliptin 100mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Dapagliflozin 10mg + Sitagliptin 100mg Tablets